Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jul 20 2016 | U.S. FDA Expands Indication for Type 2 Diabetes Treatment Synjardy® to Include Treatment-Naïve Adults Practice News Read More Jul 19 2016 | HFSA Member Spotlight: Marc Silver, MD, FHFSA Practice News Membership Read More Jul 18 2016 | FDA Approves First and Only Single Monthly Injection for a PCSK9 Inhibitor Practice News Read More Jul 12 2016 | JAMA Article Authored by President Obama on Progress and Future of the Affordable Care Act Practice News Read More Jun 29 2016 | FDA Advisory Committee Recommends Approval of Jardiance® (Empagliflozin) for Cardiovascular Indication Practice News Read More Pagination First page « First Previous page ‹ Previous … Page 121 Page 122 Page 123 Page 124 Current page 125 Page 126 Page 127 Page 128 Page 129 … Next page Next › Last page Last »
Jul 20 2016 | U.S. FDA Expands Indication for Type 2 Diabetes Treatment Synjardy® to Include Treatment-Naïve Adults Practice News Read More
Jul 18 2016 | FDA Approves First and Only Single Monthly Injection for a PCSK9 Inhibitor Practice News Read More
Jul 12 2016 | JAMA Article Authored by President Obama on Progress and Future of the Affordable Care Act Practice News Read More
Jun 29 2016 | FDA Advisory Committee Recommends Approval of Jardiance® (Empagliflozin) for Cardiovascular Indication Practice News Read More
